2018 was a ground-breaking year for orphan disease with the FDA approving a record 34 new therapies for rare populations. Clearly, the steps laid out
Bigger isn’t necessarily better when it comes to digital marketing.
Winning techniques for pharma marketers to find, grow and keep their disease community
Leverage a scorecard to evaluate media partners
Guide evolved pharma portfolio management and planning with these principles
A roadmap for building professional trust and engagement
Transform mundane media metrics into meaningful marketing insight